Gene · 970
NIH grants2,135
NIH grants whose papers are about the gene, through NIH's grant-paper links.
741 to 760 of 2,135
Download this page as JSON| Grant | Title | CD70 papers | Newest fiscal year |
|---|---|---|---|
| ZIABC010945 | Clinical trials employing cancer vaccine combination therapies | 1 | 2022 |
| ZICBC010937 | Novel Targets for Immunotherapy | 1 | 2022 |
| P50CA097274 | Lymphoma Specialized Program of Research Excellence (SPORE) in Human Cancer | 11 | 2021 |
| R01DK113775 | CD40 monocyte in chronic kidney disease | 5 | 2021 |
| R01CA216410 | Developing Nano Technology for HER2 Directed Therapy | 4 | 2021 |
| P01AI061093 | Cellular and Molecular Defects in Human B Cell Development | 3 | 2021 |
| R01CA211044 | Off-the-shelf engineered NK cells for the treatment of AML | 3 | 2021 |
| R01HL135325 | CD27/CD70 mediated negative regulation of inflammatory T cell responses | 3 | 2021 |
| R01AI081848 | Exposing virus-induced long noncoding RNA in plasmacytoid dendritic cells | 2 | 2021 |
| R01CA206069 | Development of Targeted Nanotechnology Platform for Pancreatic Cancer | 2 | 2021 |
| R01CA208253 | Enhancing immune therapy in pancreatic cancer by targeting IL-6 | 2 | 2021 |
| R01CA210192 | Targeted Nanotherapy for Pancreatic Cancer | 2 | 2021 |
| T32CA211056 | Duke-UNC Chapel Hill Immunotherapy Training Grant | 2 | 2021 |
| U19AI090023 | System Biological Analyses of Innate and Adaptive Responses to Vaccination | 2 | 2021 |
| U19AI118610 | Dengue Human Immunology Project Consortium (DHIPC) | 2 | 2021 |
| U24CA184427 | NDEx - the Network Data Exchange A Network Commons for Biologists | 2 | 2021 |
| DP5OD024576 | Combining Radiation and Tumor-specific AntIbody Therapies to Elicit in Situ Tumor Vaccination | 1 | 2021 |
| F30CA236157 | Modulation of the anti-tumor immune response by Major Histocompatibility Class-II expression on tumor cells | 1 | 2021 |
| F32HL156516 | Defining the role of IRF5 in inflammatory hemophagocyte differentiation | 1 | 2021 |
| K08CA241070 | A Phagocytosis Modulating Nanomedicine for Targeted Breast Cancer Immunotherapy | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/grants?page=38